19 insiders have filed at DGX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Davis J. E. | CEO And President | 142.4k | 0.127% | 19 sells $19.3M | |
| Doherty Catherine T. | EVP, Regional Businesses | 71.6k | 0.064% | 18 sells $14.8M | |
| Prevoznik Michael E | SVP & General Counsel | 43.3k | 0.039% | 16 sells $19.2M | |
| Deppe Michael J | SVP, Corp. Controller & CAO | 35.2k | 0.031% | 6 sells $2.9M | |
| Samad Sam | Executive Vice President & CFO | 33.3k | 0.03% | ||
| Ring Timothy M | Director | 29.5k | 0.026% | ||
| Pfeiffer Gary M | Director | 29.4k | 0.026% | 1 sells $270k | |
| Main Timothy L | Director | 26.3k | 0.023% | ||
| Gregg Vicky B | Director | 17.1k | 0.015% | 3 sells $762k | |
| Kuppusamy Karthik | SVP, Clinical Solutions | 15.5k | 0.014% | 8 sells $3.6M | |
| Plewman Patrick | SVP For Diagnostic Services | 15.2k | 0.014% | 10 sells $4.6M | |
| Delaney Mark E | SVP & Chief Commercial Officer | 11.9k | 0.011% | 5 sells $1.9M | |
| Morrison Denise M | Director | 10.7k | 0.01% | ||
| Lassiter Wright III | Director | 9.1k | <0.01% | ||
| Doi Tracey | Director | 6.5k | <0.01% | ||
| Gardner Mark A | SVP Of Molecular Gen & Oncol | 4.7k | <0.01% | ||
| Diaz Luis | Director | 4.1k | <0.01% | ||
| Carter Robert B | Director | 2.7k | <0.01% | ||
| Wentworth Timothy C | Director | 215 | <0.01% |
Full register at boothcheck.com/insiders/DGX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.